ENGNW
enGene Holdings Inc. Warrants
NASDAQ · Healthcare · Biotechnology · CA
$0.21
−4.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-26.0%
Return on equity
-21.6%
Return on assets
-23.8%
Return on invested capital
0.00x
Asset turnover
-$110.0M
Cash from operations
$5.06
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026